Headquarters
12TH FLOOR, 555, LONG WHARF DRIVE, NEW HAVEN, CT 06511-6104, US
NEW HAVEN, CT, US
BIOXCEL THERAPEUTICS, INC.
From the company
BioXcel Therapeutics, Inc. is a biopharmaceutical company traded on Nasdaq under the symbol BTAI. It describes itself as pursuing AI-based Drug Re-innovation and maintains a pipeline and products, including IGALMI, a registered trademark of BioXcel Therapeutics, Inc. The company has an affiliate, OnkosXcel Therapeutics, and conducts clinical research including the SERENITY At-Home Phase 3 Trial for agitation associated with bipolar disorders or schizophrenia. It is headquartered at 555 Long Wharf Drive, 12th Floor, New Haven, CT 06511.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.